Sage Therapeutics Could Be In For A Depressing FDA Review
Seeking Alpha,
Follow Summary Sage Therapeutics, Inc. completed its rolling submission to the FDA for zuranolone in two indications.
Follow Summary Sage Therapeutics, Inc. completed its rolling submission to the FDA for zuranolone in two indications.
Every Thanksgiving, myths of the quasi-magical powers of tryptophan rise again.
Every Thanksgiving, myths of the quasi-magical powers of tryptophan rise again.
A new review of the data brings up some concerns about how the drugs are currently prescribed.